-
1
-
-
0022495870
-
Production of acquired immunodeficiency syndrome-associated retroviras in human and nonhuman cells transfected with an infectious molecular clone
-
Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retroviras in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
-
(1986)
J. Virol.
, vol.59
, pp. 284-291
-
-
Adachi, A.1
Gendelman, H.E.2
Koenig, S.3
Folks, T.4
Willey, R.5
Rabson, A.6
Martin, M.A.7
-
2
-
-
0034284897
-
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors
-
Bally, F., R. Martinez, S. Peters, P. Sudre, and A. Telenti. 2000. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res. Hum. Retrovir. 16:1209-1213.
-
(2000)
AIDS Res. Hum. Retrovir.
, vol.16
, pp. 1209-1213
-
-
Bally, F.1
Martinez, R.2
Peters, S.3
Sudre, P.4
Telenti, A.5
-
3
-
-
0031849665
-
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor
-
Carrillo, A., K. D. Stewart, H. L. Sham, D. W. Norbeck, W. E. Kohlbrenner, J. M. Leonard, D. J. Kempf, and A. Molla. 1998. In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. J. Virol. 72:7532-7541.
-
(1998)
J. Virol.
, vol.72
, pp. 7532-7541
-
-
Carrillo, A.1
Stewart, K.D.2
Sham, H.L.3
Norbeck, D.W.4
Kohlbrenner, W.E.5
Leonard, J.M.6
Kempf, D.J.7
Molla, A.8
-
4
-
-
0034565934
-
HIV drug resistance and viral fitness
-
Clavel, F., E. Race, and F. Mammano. 2000. HIV drug resistance and viral fitness. Adv. Pharmacol. 49:41-66.
-
(2000)
Adv. Pharmacol.
, vol.49
, pp. 41-66
-
-
Clavel, F.1
Race, E.2
Mammano, F.3
-
5
-
-
0035163687
-
Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir
-
Cote, H. C., Z. L. Brumme, and P. R. Harrigan. 2001. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir. J. Virol. 75: 589-594.
-
(2001)
J. Virol.
, vol.75
, pp. 589-594
-
-
Cote, H.C.1
Brumme, Z.L.2
Harrigan, P.R.3
-
6
-
-
0031015475
-
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors
-
Croteau, G., L. Doyon, D. Thibeault, G. McKercher, L. Pilote, and D. Lamarre. 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J. Virol. 71:1089-1096.
-
(1997)
J. Virol.
, vol.71
, pp. 1089-1096
-
-
Croteau, G.1
Doyon, L.2
Thibeault, D.3
McKercher, G.4
Pilote, L.5
Lamarre, D.6
-
7
-
-
0033552832
-
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs
-
de Jong, J. J., J. Goudsmit, V. V. Lukashov, M. E. Hillebrand, E. Baan, R. Huismans, S. A. Danner, J. H. ten Veen, F. de Wolf, and S. Jurriaans. 1999. Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS 13:75-80.
-
(1999)
AIDS
, vol.13
, pp. 75-80
-
-
Jong, J.J.1
Goudsmit, J.2
Lukashov, V.V.3
Hillebrand, M.E.4
Baan, E.5
Huismans, R.6
Danner, S.A.7
Ten Veen, J.H.8
De Wolf, F.9
Jurriaans, S.10
-
8
-
-
0041888278
-
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: An indication of viral fitness?
-
de Oliveira, T., S. Engelbrecht, E. Janse van Rensburg, M. Gordon, K. Bishop, J. zur Megede, S. W. Barnett, and S. Cassol. 2003. Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness? J. Virol. 77:9422-9430.
-
(2003)
J. Virol.
, vol.77
, pp. 9422-9430
-
-
De Oliveira, T.1
Engelbrecht, S.2
Van Janse Rensburg, E.3
Gordon, M.4
Bishop, K.5
Zur Megede, J.6
Barnett, S.W.7
Cassol, S.8
-
9
-
-
0028152948
-
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma
-
Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. T. Davey, Jr., J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1172-1179.
-
(1994)
J. Infect. Dis.
, vol.170
, pp. 1172-1179
-
-
Dewar, R.L.1
Highbarger, H.C.2
Sarmiento, M.D.3
Todd, J.A.4
Vasudevachari, M.B.5
Davey Jr., R.T.6
Kovacs, J.A.7
Salzman, N.P.8
Lane, H.C.9
Urdea, M.S.10
-
10
-
-
0029899093
-
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors
-
Doyen, L., G. Croteau, D. Thibeault, F. Poulin, L. Pilote, and D. Lamarre. 1996. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70:3763-3769.
-
(1996)
J. Virol.
, vol.70
, pp. 3763-3769
-
-
Doyen, L.1
Croteau, G.2
Thibeault, D.3
Poulin, F.4
Pilote, L.5
Lamarre, D.6
-
11
-
-
0017289168
-
Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy
-
Gonda, M. A., S. A. Aaronson, N. Ellmore. V. H. Zeve, and K. Nagashima. 1976. Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J. Natl. Cancer Inst. 56:245-263.
-
(1976)
J. Natl. Cancer Inst.
, vol.56
, pp. 245-263
-
-
Gonda, M.A.1
Aaronson, S.A.2
Ellmore, N.3
Zeve, V.H.4
Nagashima, K.5
-
12
-
-
0023926115
-
Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives
-
Haertle, T., C. J. Carrera, D. B. Wasson, L. C. Sowers, D. D. Richman, and D. A. Carson. 1988. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J. Biol. Chem. 263: 5870-5875.
-
(1988)
J. Biol. Chem.
, vol.263
, pp. 5870-5875
-
-
Haertle, T.1
Carrera, C.J.2
Wasson, D.B.3
Sowers, L.C.4
Richman, D.D.5
Carson, D.A.6
-
13
-
-
0022404296
-
Infection of HTLV-III/LAV in HTLV-carrying cells MT-2 and MT-4 and application in a plaque assay
-
Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566.
-
(1985)
Science
, vol.229
, pp. 563-566
-
-
Harada, S.1
Koyanagi, Y.2
Yamamoto, N.3
-
14
-
-
0031958266
-
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro
-
Harrigan, P. R., B. Stuart, and B. A. Larder. 1998. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J. Virol. 72:3773-3778.
-
(1998)
J. Virol.
, vol.72
, pp. 3773-3778
-
-
Harrigan, P.R.1
Stuart, B.2
Larder, B.A.3
-
15
-
-
0034469498
-
Relative replication fitness of a high-level 3′Azido-3′- deoxythimidien resistant variant of human Immunodeficiency virus type-1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr to Gly) at codon 69
-
Imamichi, T., S. C. Berg, H. Imamichi, J. C. Lopez, J. A. Metcalf, J. Falloon, and H. C. Lane. 2000. Relative replication fitness of a high-level 3′Azido-3′-deoxythimidien resistant variant of human Immunodeficiency virus type-1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr to Gly) at codon 69. J. Virol. 74:10958-10964.
-
(2000)
J. Virol.
, vol.74
, pp. 10958-10964
-
-
Imamichi, T.1
Berg, S.C.2
Imamichi, H.3
Lopez, J.C.4
Metcalf, J.A.5
Falloon, J.6
Lane, H.C.7
-
16
-
-
0742290185
-
HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization
-
Kagan, R., M. Winters, T. Merigan, and P. Heseltine. 2004. HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilization. AIDS Res. Hum. Retrovir. 20:1-9.
-
(2004)
AIDS Res. Hum. Retrovir.
, vol.20
, pp. 1-9
-
-
Kagan, R.1
Winters, M.2
Merigan, T.3
Heseltine, P.4
-
17
-
-
0033834920
-
Virological and immunological characteristics of HIV treatment failure
-
Kaufmann, D., M. Munoz, G. Bleiber, S. Fleury, B. Lotti, R. Martinez, W. Pichler, P. Meylan, and A. Telenti. 2000. Virological and immunological characteristics of HIV treatment failure. AIDS 14:1767-1774.
-
(2000)
AIDS
, vol.14
, pp. 1767-1774
-
-
Kaufmann, D.1
Munoz, M.2
Bleiber, G.3
Fleury, S.4
Lotti, B.5
Martinez, R.6
Pichler, W.7
Meylan, P.8
Telenti, A.9
-
18
-
-
0034764066
-
Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients
-
Kim, E. Y., M. A. Winters, R. M. Kagan, and T. C. Merigan. 2001. Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients. J. Virol. 75:11227-11233.
-
(2001)
J. Virol.
, vol.75
, pp. 11227-11233
-
-
Kim, E.Y.1
Winters, M.A.2
Kagan, R.M.3
Merigan, T.C.4
-
19
-
-
0005241362
-
Active human immunodeficiency virus protease is required for viral infectivity
-
Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85:4686-4690.
-
(1988)
Proc. Natl. Acad. Sci. USA
, vol.85
, pp. 4686-4690
-
-
Kohl, N.E.1
Emini, E.A.2
Schleif, W.A.3
Davis, L.J.4
Heimbach, J.C.5
Dixon, R.A.6
Scolnick, E.M.7
Sigal, I.S.8
-
20
-
-
0013610170
-
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
-
Kovacs, J. A., S. Vogel, J. M. Albert, J. Falloon, R. T. Davey, Jr., R. E. Walker, M. A. Polis, K. Spooner, J. A. Metcalf, M. Baseler, G. Fyfe, and H. C. Lane. 1996. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 335:1350-1356.
-
(1996)
N. Engl. J. Med.
, vol.335
, pp. 1350-1356
-
-
Kovacs, J.A.1
Vogel, S.2
Albert, J.M.3
Falloon, J.4
Davey Jr., R.T.5
Walker, R.E.6
Polis, M.A.7
Spooner, K.8
Metcalf, J.A.9
Baseler, M.10
Fyfe, G.11
Lane, H.C.12
-
21
-
-
0032817241
-
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
-
Larder, B. A., S. Bloor, S. D. Kemp, K. Hertogs, R. L. Desmet, V. Miller, M. Sturmer, S. Staszewski, J. Ren, D. K. Stammers, D. I. Stuart, and R. Pauwels. 1999. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob. Agents Chemother. 43:1961-1967.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 1961-1967
-
-
Larder, B.A.1
Bloor, S.2
Kemp, S.D.3
Hertogs, K.4
Desmet, R.L.5
Miller, V.6
Sturmer, M.7
Staszewski, S.8
Ren, J.9
Stammers, D.K.10
Stuart, D.I.11
Pauwels, R.12
-
22
-
-
0036063882
-
Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase
-
Lobato, R. L., E. Y. Kim, R. M. Kagan, and T. C. Merigan. 2002. Genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of HIV type 1 reverse transcriptase. AIDS Res. Hum. Retrovir. 18:733-736.
-
(2002)
AIDS Res. Hum. Retrovir.
, vol.18
, pp. 733-736
-
-
Lobato, R.L.1
Kim, E.Y.2
Kagan, R.M.3
Merigan, T.C.4
-
23
-
-
12144286765
-
Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity
-
Logsdon, B. C., J. F. Vickrey, P. Martin, G. Proteasa, J. I. Koepke, S. R. Terlecky, Z. Wawrzak, M. A. Winters, T. C. Merigan, and L. C. Kovari. 2004. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity. J. Virol. 78:3123-3132.
-
(2004)
J. Virol.
, vol.78
, pp. 3123-3132
-
-
Logsdon, B.C.1
Vickrey, J.F.2
Martin, P.3
Proteasa, G.4
Koepke, J.I.5
Terlecky, S.R.6
Wawrzak, Z.7
Winters, M.A.8
Merigan, T.C.9
Kovari, L.C.10
-
24
-
-
0031846317
-
Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
-
Mammano, F., C. Petit, and F. Clavel. 1998. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J. Virol. 72:7632-7637.
-
(1998)
J. Virol.
, vol.72
, pp. 7632-7637
-
-
Mammano, F.1
Petit, C.2
Clavel, F.3
-
25
-
-
28844446162
-
Wide-open" 1.3 a structure of a multidrug-resistant HIV-1 protease as a drug target
-
Martin, P., J. F. Vickrey, G. Proteasa, Y. L. Jimenez, Z. Wawrzak, M. A. Winters, T. C. Merigan, and L. C. Kovari. 2005. "Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target. Structure 13:1887-1895.
-
(2005)
Structure
, vol.13
, pp. 1887-1895
-
-
Martin, P.1
Vickrey, J.F.2
Proteasa, G.3
Jimenez, Y.L.4
Wawrzak, Z.5
Winters, M.A.6
Merigan, T.C.7
Kovari, L.C.8
-
26
-
-
0032928065
-
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
-
Martinez-Picado, J., A. V. Savara, L. Sutton, and R. T. D'Aquila. 1999. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1. J. Virol. 73:3744-3752.
-
(1999)
J. Virol.
, vol.73
, pp. 3744-3752
-
-
Martinez-Picado, J.1
Savara, A.V.2
Sutton, L.3
D'Aquila, R.T.4
-
27
-
-
0034999828
-
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): Multicenter study of patients treated with RT inhibitors
-
Masquelier, B., E. Race, C. Tamalet, D. Descamps, J. Izopet, C. Buffet-Janvresse, A. Ruffault, A. S. Mohammed, J. Cottalorda, A. Schmuck, V. Calvez, E. Dam, H. Fleury, F. Brun-Vezinet, and ANRS AC11 Resistance Study Group. 2001. Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. Antimicrob. Agents. Chemother. 45:1835-1842.
-
(2001)
Antimicrob. Agents. Chemother.
, vol.45
, pp. 1835-1842
-
-
Masquelier, B.1
Race, E.2
Tamalet, C.3
Descamps, D.4
Izopet, J.5
Buffet-Janvresse, C.6
Ruffault, A.7
Mohammed, A.S.8
Cottalorda, J.9
Schmuck, A.10
Calvez, V.11
Dam, E.12
Fleury, H.13
Brun-Vezinet, F.14
-
28
-
-
0032804864
-
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
-
Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher. 1999. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13:2349-2359.
-
(1999)
AIDS
, vol.13
, pp. 2349-2359
-
-
Nijhuis, M.1
Schuurman, R.2
De Jong, D.3
Erickson, J.4
Gustchina, E.5
Albert, J.6
Schipper, P.7
Gulnik, S.8
Boucher, C.A.9
-
29
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
Palella, F. J., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg, et al. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853-860.
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 853-860
-
-
Palella, F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
Aschman, D.J.7
Holmberg, S.D.8
-
30
-
-
0031942021
-
The regulation of sequential processing of HIV-1 Gag by the viral protease
-
Pettit, S. C., N. Sheng, R. Tritch, S. Erickson-Viitanen, and R. Swanstrom. 1998. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv. Exp. Med. Biol. 436:15-25.
-
(1998)
Adv. Exp. Med. Biol.
, vol.436
, pp. 15-25
-
-
Pettit, S.C.1
Sheng, N.2
Tritch, R.3
Erickson-Viitanen, S.4
Swanstrom, R.5
-
31
-
-
0034492631
-
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy
-
Picchio, G. R., H. Valdez, R. Sabbe, A. L. Landay, D. R. Kuritzkes, M. M. Lederman, and D. E. Mosier. 2000. Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy. J. Acquir. Immune Defic. Syndr. 25:289-295.
-
(2000)
J. Acquir. Immune Defic. Syndr.
, vol.25
, pp. 289-295
-
-
Picchio, G.R.1
Valdez, H.2
Sabbe, R.3
Landay, A.L.4
Kuritzkes, D.R.5
Lederman, M.M.6
Mosier, D.E.7
-
32
-
-
0347989161
-
The causes and consequences of HIV evolution
-
Rambaut, A., D. Posada, K. A. Crandall, and E. C. Holmes. 2004. The causes and consequences of HIV evolution. Nat. Rev. Genet. 5:52-61.
-
(2004)
Nat. Rev. Genet.
, vol.5
, pp. 52-61
-
-
Rambaut, A.1
Posada, D.2
Crandall, K.A.3
Holmes, E.C.4
-
33
-
-
0034632745
-
HIV type 1 protease cleavage site mutations and viral fitness: Implications for drug susceptibility phenotyping assays
-
Robinson, L. H., R. E. Myers, B. W. Snowden, M. Tisdale, and E. D. Blair. 2000. HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays. AIDS Res. Hum. Retrovir. 16:1149-1156.
-
(2000)
AIDS Res. Hum. Retrovir.
, vol.16
, pp. 1149-1156
-
-
Robinson, L.H.1
Myers, R.E.2
Snowden, B.W.3
Tisdale, M.4
Blair, E.D.5
-
34
-
-
0001113422
-
Mutations in retroviral genes associated with drug resistance: 1999-2000 update
-
Schinazi, R. F., B. A. Larder, and J. W. Mellors. 2000. Mutations in retroviral genes associated with drug resistance: 1999-2000 update. Int. Antivir. News 7:46-69.
-
(2000)
Int. Antivir. News
, vol.7
, pp. 46-69
-
-
Schinazi, R.F.1
Larder, B.A.2
Mellors, J.W.3
-
35
-
-
18544407086
-
A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure
-
Sturmer, M., S. Staszewski, H. W. Doerr, and K. Hertogs. 2003. A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure. AIDS Res. Hum. Retrovir. 19:967-968.
-
(2003)
AIDS Res. Hum. Retrovir.
, vol.19
, pp. 967-968
-
-
Sturmer, M.1
Staszewski, S.2
Doerr, H.W.3
Hertogs, K.4
-
36
-
-
20444387210
-
Detection of a new 3-base pair insertion mutation in the protease gene of human immunodeficiency virus type 1 during highly active antiretroviral therapy (HAART)
-
Tramuto, F., F. Bonura, S. Mancuso, N. Romano, and F. Vitale. 2005. Detection of a new 3-base pair insertion mutation in the protease gene of human immunodeficiency virus type 1 during highly active antiretroviral therapy (HAART). AIDS Res. Hum. Retrovir. 21:420-423.
-
(2005)
AIDS Res. Hum. Retrovir.
, vol.21
, pp. 420-423
-
-
Tramuto, F.1
Bonura, F.2
Mancuso, S.3
Romano, N.4
Vitale, F.5
-
37
-
-
14744272822
-
Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase
-
van der Hoek, L., N. Back, M. F. Jebbink, A. de Ronde, M. Bakker, S. Jurriaans, P. Reiss, N. Parkin, and B. Berkhout. 2005. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-acid insert in the reverse transcriptase. J. Virol. 79:3536-3543.
-
(2005)
J. Virol.
, vol.79
, pp. 3536-3543
-
-
Van Der Hoek, L.1
Back, N.2
Jebbink, M.F.3
De Ronde, A.4
Bakker, M.5
Jurriaans, S.6
Reiss, P.7
Parkin, N.8
Berkhout, B.9
-
38
-
-
0033914679
-
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
-
van Vaerenbergh, K., K. Van Laethem, J. Albert, C. A. Boucher, B. Clotet, M. Floridia, J. Gerstoft, B. Hejdeman, C. Nielsen, C. Pannecouque, L. Perrin, M. F. Pirillo, L. Ruiz, J. C. Schmit, F. Schneider, A. Schoolmeester, R. Schuurman, H. J. Stellbrink, L. Stuyver, J. Van Lunzen, B. Van Remoortel, E. Van Wijngaerden, S. Vella, M. Witvrouw, S. Yerly, E. De Clercq, J. Destmyer, and A. M. Vandamme. 2000. Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob. Agents Chemother. 44:2109-2117.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 2109-2117
-
-
Van Vaerenbergh, K.1
Van Laethem, K.2
Albert, J.3
Boucher, C.A.4
Clotet, B.5
Floridia, M.6
Gerstoft, J.7
Hejdeman, B.8
Nielsen, C.9
Pannecouque, C.10
Perrin, L.11
Pirillo, M.F.12
Ruiz, L.13
Schmit, J.C.14
Schneider, F.15
Schoolmeester, A.16
Schuurman, R.17
Stellbrink, H.J.18
Stuyver, L.19
Van Lunzen, J.20
Van Remoortel, B.21
Van Wijngaerden, E.22
Vella, S.23
Witvrouw, M.24
Yerly, S.25
De Clercq, E.26
Destmyer, J.27
Vandamme, A.M.28
more..
-
39
-
-
0032533207
-
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
-
Winters, M. A., K. L. Coolley, Y. A. Girard, D. J. Levee, H. Hamdan, R. W. Shafer, D. A. Katzenstein, and T. C. Merigan. 1998. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J. Clin. Investig. 102: 1769-1775.
-
(1998)
J. Clin. Investig.
, vol.102
, pp. 1769-1775
-
-
Winters, M.A.1
Coolley, K.L.2
Girard, Y.A.3
Levee, D.J.4
Hamdan, H.5
Shafer, R.W.6
Katzenstein, D.A.7
Merigan, T.C.8
-
40
-
-
18244384485
-
New two-amino acid insertion near codon 70 of the HIV type 1 protease gene
-
Winters, M. A., R. M. Kagan, P. N. Heseltine, and T. C. Merigan. 2005. New two-amino acid insertion near codon 70 of the HIV type 1 protease gene. AIDS Res. Hum. Retrovir. 21:311-313.
-
(2005)
AIDS Res. Hum. Retrovir.
, vol.21
, pp. 311-313
-
-
Winters, M.A.1
Kagan, R.M.2
Heseltine, P.N.3
Merigan, T.C.4
-
41
-
-
0027218692
-
Structure-based inhibitors of HIV-1 protease
-
Wlodawer, A., and J. W. Erickson. 1993. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:543-583.
-
(1993)
Annu. Rev. Biochem.
, vol.62
, pp. 543-583
-
-
Wlodawer, A.1
Erickson, J.W.2
-
42
-
-
20244387096
-
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments
-
Wu, T. D., C. A. Schiffer, M. J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A. R. Zolopa, W. J. Fessel, and R. W. Shafer. 2003. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 77:4836-4847.
-
(2003)
J. Virol.
, vol.77
, pp. 4836-4847
-
-
Wu, T.D.1
Schiffer, C.A.2
Gonzales, M.J.3
Taylor, J.4
Kantor, R.5
Chou, S.6
Israelski, D.7
Zolopa, A.R.8
Fessel, W.J.9
Shafer, R.W.10
-
43
-
-
0037055025
-
Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel
-
Yeni, P. G., S. M. Hammer, C. C. Carpenter, D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, M. S. Saag, M. Schechter, R. T. Schooley, M. A. Thompson, S. Vella, and P. A. Volberding. 2002. Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel. JAMA 288:222-235.
-
(2002)
JAMA
, vol.288
, pp. 222-235
-
-
Yeni, P.G.1
Hammer, S.M.2
Carpenter, C.C.3
Cooper, D.A.4
Fischl, M.A.5
Gatell, J.M.6
Gazzard, B.G.7
Hirsch, M.S.8
Jacobsen, D.M.9
Katzenstein, D.A.10
Montaner, J.S.11
Richman, D.D.12
Saag, M.S.13
Schechter, M.14
Schooley, R.T.15
Thompson, M.A.16
Vella, S.17
Volberding, P.A.18
-
44
-
-
0031946007
-
Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
-
Zennou, V., F. Mammano, S. Paulous, D. Mathez, and F. Clavel. 1998. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo. J. Virol. 72:3300-3306.
-
(1998)
J. Virol.
, vol.72
, pp. 3300-3306
-
-
Zennou, V.1
Mammano, F.2
Paulous, S.3
Mathez, D.4
Clavel, F.5
-
45
-
-
0030769354
-
Drug resistance during indinavir-therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites
-
Zhang, Y. M., H. Imamichi, T. Imamichi, H. C. Lane, J. Falloon, M. B. Vasudevachari, and N. P. Salzman. 1997. Drug resistance during indinavir-therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J. Virol. 71:6662-6670.
-
(1997)
J. Virol.
, vol.71
, pp. 6662-6670
-
-
Zhang, Y.M.1
Imamichi, H.2
Imamichi, T.3
Lane, H.C.4
Falloon, J.5
Vasudevachari, M.B.6
Salzman, N.P.7
|